arrow
Back

陈丽昆 (Likun Chen)

State Key Laboratory of Oncology in South China

27H-index
196Paper Count
2.8KCitation Count
Published Papers 57
Publication Date
Izalontamab brengitecan (Iza-bren; BL-B01D1), a first-in-class EGFR-HER3 bispecific antibody–drug conjugate, for patients with EGFR-mutated NSCLC: Pooled analysis of phase 1 and phase 2 trials
err2026-01-27
err0
PREAI
errS.-D. Hong; Y.-S. Wang; H.-Y. Zhao; Y.-Y. Zhao; Q.-M. Wang; Y.-X. Ma; Y.-S. Li; Y. Huang; Y.-P. Yang; Z.-M. Fu; L.-K. Chen; F. Zhou; J. Yang; X.-Y. Li; X. Hou; N.-N. Zhou; L.-H. Sun; G.-F. Zhang; J.-W. Cui; L. Wu
errShare
errSave
Magnetic resonance-guided split-course hypo-fractionated radiotherapy with concurrent chemotherapy and consolidative immunotherapy in locally advanced non-small cell lung cancer: A single arm, phase 2 study
errCANCER
IF5.1
err2025-12-15
err0
errOAAI
errZhang, Pengxin; Wang, Daquan; Yin, Shaohan; Dong, Yumei; Wei, Shihong; Liu, Fangjie; Zhang, Haoting; Xia, Biao; Situ, Yu; Wang, Mengru; Hu, Yi; Liu, Qianwen; Chen, Likun; Qiu, Bo; Liu, Hui
errShare
errSave
Efficacy and safety with aumolertinib plus anlotinib for untreated EGFR-mutant NSCLC with brain metastases
err2025-12-01
err0
errOAAI
errJing Chen; Yin Pan; Meichen Li; Hui Yu; Baishen Zhang; Mingjie Yu; Xue Hou; Likun Chen
errShare
errSave
Bevacizumab plus chemotherapy versus chemotherapy in untreated advanced non-squamous non-small-cell lung cancer patients with brain metastases (BAP BRAIN): an open-label, randomized, multicenter, phase III study
err2025-11-20
err0
errOAAI
errM. Li; Y. Pan; G. Jiang; Q. Wang; G. Wu; W. Feng; C. Zhou; Q. Bu; S. Ma; H. Jiang; J. Chen; H. Yu; M. Yu; Q. Liu; X. Hou; L. Chen
errShare
errSave
Comparison of the Efficacy of Different First-Line Therapies for EGFR L858R-Mutated NSCLC Patients With Brain Metastases
err2025-08-15
err0
errOAAI
errJing Chen; Yin Pan; Baishen Zhang; Meichen Li; Hui Yu; Mingjie Yu; Likun Chen
errShare
errSave
Continuing immune checkpoint inhibitors after progression: Real-world patterns of care and outcomes in second-line treatment for extensive-stage small-cell lung cancer
err2025-01-01
err0
PREAI
errZhang, Baishen; Bao, Hejing; Li, Zhanquan; Chen, Jing; Yu, Hui; Li, Meichen; Cai, Muyan; Chen, Likun
errShare
errSave
Ivonescimab Plus Chemotherapy in Non-Small Cell Lung Cancer With EGFR Variant A Randomized Clinical Trial
err2024-08-20
err9
errOAAI
errFang, Wenfeng; Zhao, Yuanyuan; Luo, Yongzhong; Yang, Runxiang; Huang, Yan; He, Zhiyong; Zhao, Hui; Li, Mingjun; Li, Kai; Song, Qibing; Du, Xiaobo; Sun, Yulan; Li, Wei; Xu, Fei; Wang, Zhiyu; Yang, Kunning; Fan, Yun; Liu, Baogang; Zhao, Hongyun; Hu, Ying; Jia, Li; Xu, Shen; Yi, Tienan; Lv, Dongqing; Lan, Haitao; Li, Mengxia; Liang, Wenhua; Wang, Yongsheng; Yang, Hui; Jia, Yuming; Chen, Yuan; Lu, Junguo; Feng, Jifeng; Liu, Chunling; Zhou, Ming; Zhou, Jianya; Liu, Xianling; Zhou, Ningning; He, Ming; Dong, Xiaorong; Chen, Hualin; Chen, Yongxing; Su, Haichuan; Li, Xiaoling; Zhang, Zhihong; Yang, Lei; Cheng, Ying; Chen, Likun; Hou, Xue; Zhang, Yu; Guo, Jun; Wang, Zhen; Lu, Hong; Wu, Di; Feng, Weineng; Li, Wen; Huang, Jianan; Wang, Yan; Song, Xia; Peng, Jiewen; Liu, Laiyu; Guo, Yubiao; Li, Wenting; Lu, Dongmei; Hu, Mingxiu; Wang, Zhongmin Maxwell; Li, Baiyong; Xia, Michelle; Zhang, Li
errShare
errSave
Chemotherapy versus chemotherapy plus immune checkpoint inhibitors for the first-line treatment of unresectable thymic carcinoma: A multicenter retrospective study
err2024-04-12
err0
errOAAI
errZhang, Baishen; Liu, Yao; Chen, Zhiting; Chen, Jing; Yu, Hui; Li, Meichen; Ma, Shudong; Cheng, Chao; Chen, Likun
errShare
errSave
Cerebrospinal fluid immunological cytokines predict intracranial tumor response to immunotherapy in non-small cell lung cancer patients with brain metastases
err2023-12-07
err0
errOAAI
errLi, Meichen; Chen, Jing; Yu, Hui; Zhang, Baishen; Hou, Xue; Jiang, Honghua; Xie, Dan; Chen, Likun
errShare
errSave
errShare
errSave
RETRACTION: N6-methyladenosine induced mir-143-3p promotes the brain metastasis of lung cancer via regulation of VASH1 (vol 18, 181, 2009) (Retraction of Vol 18, art no 181, 2019)
err2023-08-12
err0
errOAAI
errWang, Hongsheng; Deng, Qianqian; Lv, Ziyan; Ling, Yuyi; Hou, Xue; Chen, Zhuojia; Dinglin, Xiaoxiao; Ma, Shuxiang; Li, Delan; Wu, Yingmin; Peng, Yanxi; Huang, Hongbing; Chen, Likun
errShare
errSave
RETRACTION: p300 promotes proliferation, migration, and invasion via inducing epithelial-mesenchymal transition in non-small cell lung cancer cells (Retraction of Vol 18, art no 641, 2018)
err2023-04-30
err0
errOAAI
errHou, Xue; Gong, Run; Zhan, Jianhua; Zhou, Ting; Ma, Yuxiang; Zhao, Yuanyuan; Zhang, Yaxiong; Chen, Gang; Zhang, Zhonghan; Ma, Shuxiang; Chen, Xi; Gao, Fangfang; Hong, Shaodong; Luo, Fan; Fang, Wenfeng; Yang, Yunpeng; Huang, Yan; Chen, Likun; Yang, Haoxian; Zhang, Li
errShare
errSave
N6-Methyladenosine Promotes Translation of VEGFA to Accelerate Angiogenesis in Lung Cancer
err2023-04-27
err25
errOAAI
errZhang, Haisheng; Zhou, Jiawang; Li, Jiexin; Wang, Zhaotong; Chen, Zhuojia; Lv, Ziyan; Ge, Lichen; Xie, Guoyou; Deng, Guoming; Rui, Yalan; Huang, Hongbing; Chen, Likun; Wang, Hongsheng
errShare
errSave
Androgen Signaling Contributes to Sex Differences in Cancer by Inhibiting NF-KB Activation in T Cells and Suppressing Antitumor Immunity
err2023-01-12
err29
errOAAI
errZhang, Xiaomin; Cheng, Limin; Gao, Chengqi; Chen, Jing; Liao, Shuangye; Zheng, Yongqiang; Xu, Liping; He, Jingjing; Wang, Danyang; Fang, Ziqian; Zhang, Jianeng; Yan, Min; Luan, Yi; Chen, Siyu; Chen, Likun; Xia, Xiaojun; Deng, Chunhao; Chen, Guokai; Li, Wende; Liu, Zexian; Zhou, Penghui
errShare
errSave